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Abstract
Background: Mitochondrial replacement (MR) therapy is a new assisted reproductive technology that allows
women with mitochondrial disorders to give birth to healthy children by combining their nuclei with mitochondria
from unaffected egg donors. Evolutionary biologists have raised concerns about the safety of MR therapy based on
the extent to which nuclear and mitochondrial genomes are observed to co-evolve within natural populations, i.e.
the nuclear-mitochondrial mismatch hypothesis. In support of this hypothesis, a number of previous studies on
model organisms have provided evidence for incompatibility between nuclear and mitochondrial genomes from
divergent populations of the same species.
Results: We tested the nuclear-mitochondrial mismatch hypothesis for humans by observing the extent of naturally
occurring nuclear-mitochondrial mismatch seen for 2,504 individuals across 26 populations, from 5 continental
populations groups, characterized as part of the 1000 Genomes Project (1KGP). We also performed a replication
analysis on mitochondrial DNA (mtDNA) haplotypes for 1,043 individuals from 58 populations, characterized as part
of the Human Genome Diversity Project (HGDP). Nuclear DNA (nDNA) and mtDNA sequences from the 1KGP were
directly compared within and between populations, and the population distributions of mtDNA haplotypes derived
from both sequence (1KGP) and genotype (HGDP) data were evaluated. Levels of nDNA and mtDNA pairwise
sequence divergence are highly correlated, consistent with their co-evolution among human populations. However,
there are numerous cases of co-occurrence of nuclear and mitochondrial genomes from divergent populations
within individual humans. Furthermore, pairs of individuals with closely related nuclear genomes can have highly
divergent mtDNA haplotypes. Supposedly mismatched nuclear-mitochondrial genome combinations are found not
only within individuals from populations known to be admixed, where they may be expected, but also from
populations with low overall levels of observed admixture.
Conclusions: These results show that mitochondrial and nuclear genomes from divergent human populations can
co-exist within healthy individuals, indicating that mismatched nDNA-mtDNA combinations are not deleterious or
subject to purifying selection. Accordingly, human nuclear-mitochondrial mismatches are not likely to jeopardize
the safety of MR therapy.
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Background
Mutations to mitochondrial DNA (mtDNA) have been
associated with a wide range of human diseases [1, 2].
Since mitochondria are maternally inherited, mitochon-
drial genetic disorders will be passed from mothers to
their children. Effective treatments for mitochondrial
disease are rare, and patients are often faced with limited
therapeutic options. Furthermore, the ability to accur-
ately assess the risk of inheriting a mitochondrial genetic
disorder can be complicated by the co-occurrence of
wild-type and mutated mtDNA (i.e., heteroplasmy) in a
single female [3]. Mitochondrial replacement (MR) ther-
apy is a promising new assisted reproductive technology
that could allow women with mitochondrial disorders to
give birth to healthy children to whom they are closely
genetically related. MR therapy works by combining nu-
clear DNA (nDNA) from a mother who has a mitochon-
drial disorder together with healthy mitochondria from
an egg donor. For MR-assisted in vitro fertilization
(IVF), the nuclear genome is removed from a fertilized
oocyte with diseased mitochondria and injected into an
enucleated donor egg that contains healthy mitochon-
dria. This process results in so-called ‘three-person ba-
bies’ since children born from MR therapy will have
genetic contributions from two mothers and one father.
Studies in mammalian systems over the last decade
have underscored both the surmountable technical chal-
lenges, and the considerable promise, associated with
MR therapy. The nuclear transplantation procedure that
underlies MR therapy was first shown to be possible in
mice [4]. The progeny of nuclear transplantations from
mouse oocytes with mitochondrial disease into healthy
oocytes were found to be viable and disease-free. Later
in primates, MR therapy was used to produce four
Macaque offspring [5] that showed healthy development
to 3 years of age [6]. Nuclear transfer in this case oc-
curred prior to fertilization, a technique that has not
proven to be equally effective in humans. The MR pro-
cedure was first developed in humans using abnormally
fertilized zygotes [7]. Human MR experiments rely on
pronuclear transfer, whereby the nuclear genome is re-
moved from a newly formed human embryo shortly after
fertilization. This approach showed promise with respect
to both the small amount of diseased mitochondria that
are carried over to the healthy donor egg and in terms
of normal in vitro development through the blastocyst
stage. More recently, the same group demonstrated even
greater efficacy of the pronuclear transfer technique for
MR therapy with normally fertilized embryos by trans-
ferring the pronuclei compartments containing maternal
and paternal haploid genomes almost immediately after
they first appear [8].
These crucial experimental advances in MR therapy
have occurred against a backdrop of substantial regulatory
investigation related to the technique’s desirability, safety
and potential efficacy [9]. Most of the effort and progress
on this front has occurred in the United Kingdom (UK).
The UK’s Human Fertilisation and Embryology Authority
(HFEA) was initially charged with evaluating MR
therapy, and they recommended further studies before
the technique could be adopted as a clinical practice.
Subsequently, several independent UK science agencies
supported the bioethics of MR therapy, and the public
was found to be largely in favor of its use. These findings
ultimately led the UK government to draft a set of regula-
tions for the technique, and parliament approved MR
therapy as an assisted reproductive technology in February
of 2015. Regulations were to be enacted by October of the
same year, with clinics able to apply for a license by
November. Initial attempts to conceive via MR-assisted
IVF could have begun by the end of that same year. When
this manuscript was written, there was no record of any
human birth resulting from MR therapy in the UK. How-
ever, during the manuscript review process, news broke of
a ‘three-person baby’ resulting from MR therapy born in
Mexico [10]. The United States (US) doctors who led the
procedure chose Mexico to avoid US regulations that do
not yet permit MR therapy, leading to charges of unethical
and irresponsible behavior.
Despite the considerable technical and regulatory pro-
gress that has been made on the issue, substantial con-
cerns have been raised about the safety of MR therapy
[9, 11]. These concerns rest largely on the notion of po-
tential incompatibility (mismatches) between nuclear and
mitochondrial genomes from different populations of the
same species. We refer to this idea here as the ‘nuclear-
mitochondrial mismatch hypothesis’. Incompatibility be-
tween nuclear and mitochondrial genomes from divergent
populations would most likely be predicated upon interac-
tions between proteins encoded by each [11]. While the
human mitochondrial genome only encodes 37 protein
coding genes, there are more than a thousand nuclear
genes that encode proteins involved in mitochondrial
function. These include 76 nuclear encoded proteins that
directly bind mitochondrial counterparts. Sequence varia-
tions that change the binding affinities between nuclear
and mitochondrial proteins could have deleterious effects,
which would jeopardize healthy outcomes from MR
therapy. This possibility has been supported by com-
parative sequence analyses showing the importance of
compensatory sequence changes that serve to main-
tain physical interactions between nuclear and mito-
chondrial encoded proteins [12, 13].
A number of studies from model organisms have pro-
vided even more direct evidence for incompatibility be-
tween nuclear and mitochondrial genomes brought
together from different populations of the same species.
For example, mice with mismatched mitochondrial and
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nuclear genomes were able to survive to adulthood but
showed stunted growth and reduced physical perform-
ance [14] as well as reduced learning and exploratory be-
havior [15]. The neurological effects observed in the
latter study increased with age. Analogous studies in in-
vertebrates have also turned up numerous deleterious ef-
fects of combining divergent nuclear and mitochondrial
genomes. Such effects include changes in aging [16–19],
survival [20] and fertility [21–24] along with impaired
mitochondrial function [25, 26]. It should be noted that
all of these studies entailed repeated genetic backcrosses
whereby divergent mitochondria were introduced into
highly inbred lines. As such, they represent extremes of
genetic divergence between lineages and are not likely to
accurately reflect human populations that routinely inter-
breed [27]. Nevertheless, these findings do point to a
number of possible complications arising from nuclear-
mitochondrial genome mismatch.
While the aforementioned studies have revealed in-
stances of nuclear-mitochondrial incompatibility by study-
ing the progression of chimeric individuals into adulthood,
MR studies in humans have been conducted in vitro and
only followed embryos through the blastula stage of devel-
opment. This has led to calls for additional preclinical trials
of MR therapy with a much longer time horizon [9]. How-
ever, it has occurred to us that long term experiments of
this kind have already been conducted in nature via the
process of human evolution. The evolutionary history of
anatomically modern humans has been characterized by
relatively long periods of isolation and genetic divergence
interspersed with migrations and genetic admixture be-
tween previously isolated populations [28–30]. Admixture
between genetically distinct human populations should
have brought together divergent nuclear and mitochondrial
genomes. Evidence that this is in fact the case could be
taken to refute the nuclear-mitochondrial genome mis-
match hypothesis for humans and to thereby support the
feasibility of MR therapy.
In light of this realization, we systematically evaluated
the extent of naturally occurring nuclear-mitochondrial
genome swapping that has occurred among human popu-
lations. The goal of our survey was to get an idea of the
extent of nuclear-mitochondrial divergence that can be
tolerated within any single individual as well as a sense of
how often swapping has occurred in human evolution. To
do this, we evaluated the distribution of nuclear genomic
diversity and mtDNA haplotypes among the 26 human
populations, representing five major continental groups,
which were characterized via whole genome sequencing
as part of the 1000 Genomes Project (1KGP) [31]. We also
performed a confirmatory analysis of mtDNA sequence
variation among 58 populations from the Human Genome
Diversity Project (HGDP), which characterized mitochon-
drial genomes to a lower level of resolution using SNP
arrays [29]. We reasoned that since the donors for these
human genome diversity projects are (apparently) healthy
individuals, they should not bear incompatible nuclear-
mitochondrial genome combinations. In addition, since
these diverse populations have been shaped by millennia
of natural selection, deleterious combinations of nuclear-
mitochondrial genomes should have been eliminated long
ago and would not be observed in extant populations.
In this sense, our survey can be considered as a test
of the nuclear-mitochondrial genome incompatibility
hypothesis in humans.
Methods
Human population genomic data
Human genome sequence variants, characterized via whole
genome sequencing of healthy donors, for nuclear DNA
(nDNA) and mitochondrial DNA (mtDNA) were obtained
from the 1KGP [31] data portal [32]. The data analyzed
here correspond to the Phase 3 release of 1KGP [31], with
variants available for 2,054 individuals from 26 populations
representing five major continental population groups
(Table 1). For the purposes of this study, we consider
the ASW and ACB populations to be members of the
Admixed American continental population group.
HGDP mtDNA sequence variants from healthy donors
characterized via SNP arrays [29] were obtained from
the HGDP-CEPH Genome Diversity Panel Database
(version 3.0) [33]. The HGDP data analyzed here corres-
pond to the Dataset 2 release from September 2007,
with variants available for 1,043 individuals from 58 pop-
ulations representing six major continental population
groups (Additional file 1: Table S1).
Nuclear and mitochondrial genetic divergence
Genetic divergence levels between pairs of individuals,
for nDNA and mtDNA, were measured as allele sharing
distances [34] as implemented in PLINK v1.90 [35].
Allele sharing distances are calculated as the number of
different variants (d) normalized by the total number of
sites (2n) under consideration. The resulting nDNA and
mtDNA pairwise distance matrices were projected in
two dimensional space using multi-dimensional scaling
(MDS) [36] implemented in R [37, 38]. Allele sharing
distances for nDNA and mtDNA were used to recon-
struct a neighbor-joining phylogenetic trees [39] using
the program MEGA [40]. nDNA versus mtDNA allele
sharing distances were regressed, and the resulting scat-
terplot was visualized using a smoothed color density
representation in R. The Spearman correlation coeffi-
cient was used to quantify the correlation between
nDNA and mtDNA distances and the significance of the
relationship. Genetic divergence levels for nDNA and
mtDNA were ranked separately, and the ranks were
Rishishwar and Jordan BMC Genomics  (2017) 18:140 Page 3 of 11
compared in order to calculate nDNA versus mtDNA
distance-differences.
mtDNA haplotype analysis
For both the 1KGP and the HGDP data, mitochondrial
haplotypes were determined from mtDNA sequence var-
iants using the HaploGrep2 program [41]. Evolutionary
relationships among mtDNA haplogroups were taken
from the PhyloTreemt website [42]. Counts of mtDNA
haplogroups were determined for the individual popula-
tions, and the counts were hierarchically clustered ac-
cording to the continental population groups from the
1KGP and HGDP along with the origins of their previ-
ously characterized macro-haplogroups. 1KGP mtDNA
haplotypes were determined based on 3,892 sequence
variants from whole genome sequencing, whereas HGDP
mtDNA haplotypes were determined based on 162 vari-
ants from SNP arrays.
Results and discussion
Comparison of nuclear versus mitochondrial genetic
divergence
The nuclear-mitochondrial mismatch hypothesis rests
on the idea that nuclear and mitochondrial genomes co-
evolve as populations diverge and thus can be taken to
predict that nuclear DNA (nDNA) and mitochondrial
DNA (mtDNA) divergence levels will be correlated. In
other words, closely related pairs of individuals (from
within populations) should show low levels of both
nDNA and mtDNA divergence, whereas distantly related
individuals (from between populations) should have rela-
tively divergent nuclear and mitochondrial sequences.
To evaluate this prediction, we computed the nDNA
and mtDNA allele sharing distances between all pairs of
individuals from the 1KGP as described in the Materials
and Methods. The 1KGP entailed the characterization of
nuclear and mitochondrial genome sequences of 2,504
individuals across a broad range of human population
genetic diversity: 26 populations representing five major
continental population groups (Table 1). Multidimen-
sional scaling (MDS) was used to plot the evolutionary
relationships among individuals in two dimensions
(components 1 & 2 in Fig. 1a & b) based on the nDNA
and mtDNA distances. The genetic distances calculated
for nuclear DNA accurately reflect known evolution-
ary relationships among human populations (Fig. 1a)
[29, 30]. African, East Asian and European populations
occupy the three poles of human genetic diversity with
African populations relatively distinct from the others.
Admixed populations from India and the Americas oc-
cupy intermediate positions according the relative ances-
try contributions from ancient source populations.
Genetic distances calculated from mtDNA sequences
also reveal substantial genetic structure among human
populations (Fig. 1b). In the case of mtDNA, the major
groups correspond very well with previously character-
ized mtDNA haplogroups (Additional file 1: Figure S1)
[42]. The primary MDS component separates the set of
Table 1 1000 Genomes Project (1KGP) populations analyzed in this study
Short Full description N Short Full description N
Africa
(n = 504)
ESN Esan in Nigeria 99 India
(n = 489)
BEB Bengali in Bangladesh 86
GWD Gambian in Western Division,
The Gambia
113 GIH Gujarati Indian in Houston, TX 103
LWK Luhya in Webuye, Kenya 99 ITU Indian Telugu in the UK 102
MSL Mende in Sierra Leone 85 PJL Punjabi in Lahore, Pakistan 96
YRI Yoruba in Ibadan, Nigeria 108 STU Sri Lankan Tamil in the UK 102
East Asia
(n = 504)
CDX Chinese Dai in Xishuangbanna, China 93 America
(n = 504)
ACB African Caribbean in Barbados 96
CHB Han Chinese in Bejing, China 103 ASW African Ancestry in Southwest US 61
CHS Southern Han Chinese, China 105 CLM Colombian in Medellin, Colombia 94
JPT Japanese in Tokyo, Japan 104 MXL Mexican Ancestry in Los Angeles,
California
64
KHV Kinh in Ho Chi Minh City, Vietnam 99 PEL Peruvian in Lima, Peru 85
Europe
(n = 503)
CEU Utah residents with NW European
ancestry
99 PUR Puerto Rican in Puerto Rico 104
FIN Finnish in Finland 99
GBR British in England and Scotland 91
IBS Iberian populations in Spain 107
TSI Toscani in Italy 107
The continental population groups, short three letter symbols, full population name and number of individuals from each population are shown. The continental
population groups correspond to the convention used by the 1KGP with the exception of the ASW and ACB populations, which we consider as part of the
admixed American population group
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ancient L mtDNA haplogroups (L0, L1 & L5) from the
more derived L haplogroups (L3 & L4), which cluster
with the rest of the derived haplogroups. The MDS clus-
ters of the derived mtDNA haplogroups (M, N & R) also
correspond well with the previously known classification;
although, the mtDNA genetic distances provided rela-
tively little resolution within these subgroups.
We regressed the nDNA versus mtDNA pairwise
genetic distances to test for the correlation predicted by
the nuclear-mitochondrial mismatch hypothesis. Overall,
nDNA and mtDNA genetic distances are highly correlated,
consistent with the prediction (Fig. 1c). Analysis of 2,504
individuals from the 1KGP yields >3 million pairwise com-
parisons, and the nDNA and mtDNA genetic distances are
correlated at r = 0.51, P ≈ 0. Despite the high overall correl-
ation between nDNA and mtDNA genetic distances, there
is a substantial amount of spread in the differences ob-
served for pairs of nDNA versus mtDNA distances (Fig. 1c).
There are numerous pairs of individuals, the outliers in the
distance-difference distribution (Fig. 1d), that have very
closely related nuclear genomes and distantly related mito-
chondrial genomes or vice versa. These observations point
A B
C D
Fig. 1 Comparison of nuclear (nDNA) versus mitochondrial (mtDNA) genetic divergence levels. Genetic divergence levels between all pairs of
human individuals from the 1KGP were calculated as described in the Materials and Methods. a Multidimensional scaling (MDS) plot showing the
evolutionary relationships among the 1KGP individuals based on their nuclear (nDNA) genetic distances. b MDS plot showing the evolutionary
relationships among the 1KGP individuals based on their mitochondrial (mtDNA) genetic distances. Mitochondrial haplogroup designations are
shown on the plot and macro-haplogroups are indicated by grey circles. For panels A & B, individuals from different populations are color coded
as shown in the key. c Density scatterplot showing the regression of nuclear (x-axis) against mitochondrial (y-axis) genetic distances for all pairs of
individuals. Denser regions of points are shown in dark blue; outlier points are indicated as black dots. The Spearman correlation coefficient (ρ)
and corresponding P-value are shown. d Distribution of the nuclear versus mitochondrial distance-differences. A theoretical normal distribution
(red line) is superimposed over the observed distribution (grey bars)
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to healthy (viable) individuals that nevertheless have poten-
tially mismatched nuclear and mitochondrial genomes. We
attempted to further evaluate this possibility by analyzing
the distribution of mtDNA haplotypes among global
human populations.
Global distribution of mtDNA haplotypes
Human mtDNA haplotypes are widely used as markers of
maternal ancestry, and accordingly the continental origins
of mtDNA haplotype groups are well known [43]. Analysis
of nuclear DNA can also be used to resolve evolutionary
relationships among human populations and for individ-
ual ancestry assignment [29, 30]. The 1KG data (Table 1)
provide an opportunity to compare the global distribu-
tions of human mitochondrial and nuclear genetic diver-
sity and to test the hypothesis of nuclear-mitochondrial
genome incompatibility among naturally occurring popu-
lations. Mitochondrial sequence variants for the 1KGP in-
dividuals were converted into mtDNA haplotypes using
the HaploGrep2 program [41] as described in the Mate-
rials and Methods. The distributions of corresponding
mtDNA haplogroups were characterized for the 26 popu-
lations of the 1KGP as shown in Fig. 2a. The observed glo-
bal distributions of these mtDNA haplogroups correspond
well with the previously characterized origins of mtDNA
haplogroups. For example, the ancestral L haplogroup
predominates in Africa [44], whereas the D and F hap-
logroups are most frequent in East Asia [45]. The H, U
and T haplogroups are most common in Europe [46].
The observed numbers of each mtDNA haplogroup
were recorded for each individual population and clus-
tered into the five major population groups as shown in
Fig. 2b. This allowed us to evaluate the extent to which
observed mtDNA haplogroups correspond to their ex-
pected continent (or broad geographic region) of origin.
The African, East Asian and European populations show
very coherent patterns of mtDNA haplogroup distribu-
tions, whereas the Indian and American population
groups show more divergent haplogroups consistent
with their admixed origins. Indian populations show a
combination of largely European and Asian mtDNA
haplogroups, consistent with relatively ancient human
migration and admixture events that formed these popu-
lations [47, 48]. Interestingly, the Gujarati (GIH) popula-
tion from Western India shows several instances of
African haplogroups, perhaps consistent with subsequent
migrations across the Indian Ocean or along the coast.
The American populations from the 1KGP were formed
by more recent admixture between European, Native
American and African source populations [49–51]. Ac-
cordingly, individuals from these populations show
mtDNA haplogroups corresponding to each of these re-
gions. Native American mtDNA haplogroups are most
common among the four admixed Latino populations
(CLM, MXL, PEL and PUR), whereas African mtDNA
haplogroups are most common among the African-
American (ASW) and Afro-Caribbean (ACB) populations.
The prevalence of Native American haplotypes in Latino
populations is not necessarily correlated with their in-
ferred ancestry based on nuclear DNA. For example, 67%
of mtDNA haplotypes from Puerto Rico have a Native
American origin, and 13% have a European origin; analysis
of nuclear DNA, on the other hand, indicates that the
same population has 72% European ancestry compared to
only 13% Native American ancestry.
While the co-occurrence of nuclear and mitochondrial
genomes with distinct ancestries in admixed populations
may be expected, it is nevertheless inconsistent with the
nuclear-mitochondrial genome incompatibility hypoth-
esis. Perhaps even more strikingly, there are a number of
mismatched nuclear-mitochondrial genome pairs among
presumably non-admixed populations. For example, in-
dividuals from African populations in Gambia (GWD)
and Sierra Leone (MSL) have the U mtDNA haplogroup
that is most often found in Europe and India. The spe-
cific U mtDNA haplotypes found in these populations
all correspond to the U6 haplogroup. This haplogroup
has a Near East origin followed by expansion into North
Africa [52]. The presence of this haplogroup in West
African populations likely reflects subsequent contact
with North African groups [53]. A single individual from
the Beijing population (CHB) of the East Asian contin-
ental group was found to have a K mtDNA haplogroup,
which is not known to be found in East Asia [54]. Several
individuals from European populations in Spain (IBS) and
Italy (TSI) have African L mtDNA haplogroups. This
likely reflects relatively ancient African admixture that has
been documented for Southern European populations
[55]. These same two European populations also have in-
dividuals with more typically Asian mtDNA haplotypes
from the D, N and R haplogroups. It should be noted that
these particular haplogroups are widespread and have pre-
viously been found in Europe [45]. This result however
underscores the point that members of the same hap-
logroup can co-occur with nuclear genomes that have very
distinct genetic ancestries.
We performed a replication analysis of the global distribu-
tion of mtDNA haplotypes using mtDNA sequence variants
characterized with SNP arrays as part of the HGDP. While
the SNP array data from this project provide substantially
less resolution than the sequence data from the 1KGP –
162 mtDNA variants for HGDP compared to 3,892 variants
for 1KGP – we were still able to infer mtDNA haplotypes
from the HGDP variant data, albeit at a more granular level.
Nevertheless, the HGDP data also show a number of cases
of nuclear-mitochondrial lineage mismatches, thereby con-
tradicting the nuclear-mitochondrial mismatch hypothesis
(Additional file 2: Table S2).
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Fig. 2 Global distribution of mtDNA haplogroups. a Map showing the names and locations of the 1KGP populations studied here along with pie
charts showing the relative frequencies of mtDNA haplogroups for each population. The haplogroups are color coded as shown in the key. b Counts
of mtDNA haplogroups for each 1KGP population. Haplogroup counts are hierarchically clustered along both axes. The y-axis corresponds to the
1KGP continental population groups, and the x-axis corresponds to previously characterized mtDNA macro-haplogroups. The continental origins of
the mtDNA macro-haplogroups are shown. Mitochondrial haplogroups that show correspondence (i.e., are matched) between the 1KGP continental
population groups and the mtDNA macro-haplogroups are shaded in green. Mismatched mtDNA haplogroups are shaded in orange
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As an additional control analysis, we performed a
similar comparison of the distribution of the Y-DNA
haplotypes across the populations of the 1KGP. The co-
occurrence of Y-DNA and nuclear genomes with distinct
ancestries can also be observed for this dataset; however,
this appears to occur less often than seen for mtDNA
(Additional file 3: Table S3). The slight difference be-
tween the mtDNA and Y-DNA results is consistent with
previous work showing sex-specific patterns of human
migration characterized by relatively lower levels of male
migration, and higher levels of female migration, based
on the phenomenon of patrilocality [56].
Phylogenetic discordance of mtDNA haplotypes
Given the existence of a number of population mis-
matched mtDNA haplotypes, as described in the
previous section, we used a phylogenetic approach to
more directly compare nDNA genetic distances to the
distribution of mtDNA haplotypes. The nDNA genetic
distances were used to compute a phylogenetic tree re-
lating all individuals from the 1KGP, and individuals’
mtDNA haplotypes were then considered in the context
of this tree (Fig. 3). Populations belonging to the five
major continental groups are clearly resolved along this
phylogeny, underscoring the extent to which nuclear
genetic divergence recapitulates human evolutionary his-
tory. The only exception is the placement of the admixed
American populations according to their relative ancestry
proportions. The African-American populations ASW
and ACB group together with the other African popula-
tions, whereas the Peruvian population (PEL) occupies an
intermediate position owing to its relatively high levels of
Fig. 3 Phylogenetic distribution of mtDNA haplotypes. A phylogeny based on nuclear (nDNA) genetic distances is shown. Branches are color coded,
and groups are labeled, according to their 1KGP continental population groups. Individuals’ mtDNA haplotypes are superimposed on the nDNA tree.
Subtrees are expanded to show examples of very closely related pairs of individuals (i.e., sister taxa) that have divergent mtDNA haplotypes
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Native American ancestry. These same patterns can be
observed in the nDNA distance MDS plot (Fig. 1a).
The phylogenetic placement of the mtDNA haplotypes
also highlights the extent of naturally occurring nuclear-
mitochondrial genome mismatch that can be seen for
human populations. Pairs of individuals with very low
nDNA divergence levels, i.e. sister taxa on the nDNA
tree shown in Fig. 3, can have mtDNA haplotypes that
are extremely divergent (see mtDNA haplogroup tree in
Additional file 1: Figure S1). For example, two European
individuals with L1 haplotypes, which correspond to one
of the most ancient African mtDNA haplogroups, are
most closely related to individuals with the highly de-
rived H mtDNA haplogroup. Similarly, an Indian indi-
vidual with an ancient African L2 mtDNA haplotype is
most closely related to an individual with the highly de-
rived U mtDNA haplotype. In Africa, U mtDNA haplo-
types are paired with more ancient L haplotypes
reflecting gene flow from the Near East back into Africa
as previously discussed.
Conclusion
The results of our analysis on naturally occurring human
genetic variation show that nuclear and mitochondrial
genomes from divergent human populations can co-
exist within presumably healthy individuals, indicating
that such mismatched nDNA-mtDNA combinations are
not deleterious and have not been eliminated by purify-
ing selection. In other words, the long and ongoing ex-
periment of human evolution provides no evidence
whatsoever in support of the nuclear-mitochondrial mis-
match hypothesis. These results can be taken to support
the feasibility, and potential safety, of MR-assisted in
vitro fertilization, at least with respect to the compatibil-
ity of human nDNA and mtDNA genomes. Of course,
our results do not bear on any potential complications
related to the technical implementation of such a com-
plicated procedure. For example, it is extremely difficult
to ensure that none of the defective mitochondria are
transferred along with the nuclear genome. Indeed, it
was recently shown that even when only a small per-
centage of defective mitochondria are carried over in the
nuclear transfer process, they can increase in copy num-
ber and eventually replace most or all of the healthy
mitochondria from the egg donor [57]. Such technical
hurdles will need to be addressed to ensure the max-
imum safety of MR therapy.
Our results are in conflict with a number of previous
studies on model organisms, which provide numerous
lines of evidence in support of nuclear-mitochondrial
genome incompatibility. For example, studies in mice have
shown physical and neurological deficits related to
nuclear-mitochondrial mismatches [14, 15]. In addition,
the co-occurrence of divergent nuclear and mitochondrial
genomes in invertebrates has been associated with dimin-
ished mitochondrial function [25, 26] along with deleteri-
ous effects on aging [16–19], survival [20] and fertility
[21–24]. When considered together, these previous studies
have been taken to issue a strong note of caution against
MR therapy [9, 11].
It is interesting to note that much of the resistance to
MR therapy has been articulated by evolutionary biolo-
gists who emphasize the extent to which nuclear and
mitochondrial genomes co-evolve along population line-
ages [11]. This realization has raised the seemingly legit-
imate concern that advocates of MR therapy, and/or the
regulatory bodies that are charged with evaluating its
safety, may not have adequately considered the implica-
tions of evolution for the implementation of this new
technology. However, the results of our study suggest
that the model organism studies that have been used to
argue against the safety of MR therapy do not accurately
reflect the nature of human evolution [27]. For the most
part, these model organism studies relied on backcross-
ing and the generation of inbred lines, and they also in-
volved relatively divergent populations. Experiments of
this kind can be expected to result in extremes of nu-
clear-mitochondrial genome divergence. Human popula-
tions, on the other hand, tend to show both low levels of
genetic divergence and low inbreeding. Accordingly, one
may expect to see less pronounced effects of nuclear-
mitochondrial mismatch in human populations, and that
is exactly what we observed in our study.
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